Home・Akciju saraksts・Agilent Technologies Inc

Agilent Technologies Inc

Slēgts

SektorsVeselības aprūpe

139.31 -0.27

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

138.06

Max

140.31

Galvenie mērījumi
By Trading Economics
Ienākumi	34M 339M
Pārdošana	37M 1.8B
P/E Sektora vidējais	27.745 64.641
EPS	1.49
Dividenžu ienesīgums	0.73
Peļņas marža	18.474
Darbinieki	18,000
EBITDA	44M 500M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+12.11% upside

Dividendes
By Acuity
Dividenžu ienesīgums Sektora vidējais	0.73% 2.31%
Nākamie ieņēmumi	2026. g. 26. aug.
Nākamais dividenžu datums	2026. g. 21. okt.
Nākamais Ex dividenžu datums	2026. g. 29. sept.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	6.5B 39B
Iepriekšējā atvēršanas cena	139.58
Iepriekšējā slēgšanas cena	139.31

Ziņu noskaņojums

By Acuity

16%

84%

22 / 340 Rangs Healthcare

Agilent Technologies Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 31. jūl. 20:03 UTC

Agilent Technologies Inc shares are lower today, impacted by a decline in the Life Sciences Tools & Services sub-sector. No specific news was identified.

2026. g. 30. jūl. 19:58 UTC

Agilent Technologies Inc. is trading lower, continuing a decline since Wednesday's close. The Nasdaq 100 Index has increased, contrasting with Agilent's performance.

2026. g. 29. jūl. 19:56 UTC

Agilent Technologies Inc shares are lower amid broader market pressures from rising crude oil prices and inflation concerns affecting equities.

2026. g. 28. jūl. 23:41 UTC

Agilent Technologies shares declined in after-market trading, reflecting broader pressures in technology due to concerns over AI spending and competition from Chinese chipmakers.

2026. g. 27. jūl. 22:36 UTC

Agilent Technologies Inc shares are higher in after-market trading, supported by strong performance. The stock remains above its 20-day moving average.

2026. g. 24. jūl. 19:07 UTC

News

Agilent Technologies Inc shares are trading lower amid concerns over sales trends and underperformance compared to healthcare peers. The stock remains above its 20-day moving average.

2026. g. 23. jūl. 20:03 UTC

Correlated Moves

News

Agilent Technologies received EU certification for its PD-L1 IHC 22C3 diagnostic, boosting shares during Thursday's session. This marks the eighth CE-marked indication in the EU.

2026. g. 22. jūl. 21:46 UTC

Correlated Moves

Agilent Technologies Inc. is higher in after-market trading, supported by a rise in Thermo Fisher Scientific Inc. and overall life sciences sector performance.

2026. g. 21. jūl. 20:02 UTC

News

Agilent Technologies has received FDA approval for its PD-L1 IHC 28-8 assay, boosting shares as analysts express positive sentiment on its future prospects.

2026. g. 20. jūl. 19:22 UTC

News

Agilent Technologies Inc. shares are lower amid broader market declines and rising Treasury yields, despite a "Moderate Buy" consensus from analysts.

Salīdzinājums

Cenas izmaiņa

Agilent Technologies Inc Prognoze

Cenas mērķis

By TipRanks

12.11% augšup

Prognoze 12 mēnešiem

Vidējais 155.13 USD 12.11%

Augstākais 180 USD

Zemākais 135 USD

Pamatojoties uz 16 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Agilent Technologies Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

16 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 16 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Agilent Technologies Inc — pēdējo 3 mēnešu laikā.

Noskaņojums

By Acuity

22 / 340 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.